Last update 11 Jul 2024

Anti-CD19/CD20/CD22 CAR T-Cells(Ohio State University Comprehensive Cancer Centerc)

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms-
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors), CD22 inhibitors(CD22 inhibitors)
+ [2]
Inactive Indication-
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute lymphoblastic leukemia recurrentPhase 1
US
30 Jun 2022
Non-Hodgkin's lymphoma refractoryPhase 1
US
30 Jun 2022
Recurrent B Acute Lymphoblastic LeukemiaPhase 1
US
30 Jun 2022
Recurrent Indolent Non-Hodgkin LymphomaPhase 1
US
30 Jun 2022
Recurrent Transformed Chronic Lymphocytic LeukemiaPhase 1
US
30 Jun 2022
Refractory B Acute Lymphoblastic LeukemiaPhase 1
US
30 Jun 2022
Refractory B-Cell Prolymphocytic LeukemiaPhase 1
US
30 Jun 2022
Refractory High-Grade B-Cell LymphomaPhase 1
US
30 Jun 2022
Refractory Indolent Non-Hodgkin LymphomaPhase 1
US
30 Jun 2022
Refractory Transformed Chronic Lymphocytic LeukemiaPhase 1
US
30 Jun 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free